December 18, 2015

December 18, 2015

Mental health status prior to bladder cancer surgery can indicate risk of complications
eCancer News – Dec. 18
"Prior studies have suggested that poor baseline mental health can lead to more significant postoperative complications possibly due to impaired immune response associated with higher levels of stress," explained Scott M. Gilbert, MD, MS, of the H. Lee Moffitt Cancer Center, Tampa, FL.

El tratamiento se basa en un inhibidor “altamente selectivo y potente”
Navarra Informacion. - Dec. 18
En el estudio, además de dos laboratorios del TSRI, una de las de las mayores organizaciones centrada en la investigación biomédica, también han participado científicos del Moffitt Cancer Center, también de Florida. 

Moffitt salutes Grudens’ giving, unveil Huddle Room
Tampa Tribune – Dec. 18
The ESPN analyst and former coach of the Tampa Bay Buccaneers was honored along with his wife, Cindy, at the H. Lee Moffitt Cancer Center & Research Institute’s new satellite facility Thursday for their legacy of charitable endeavors as the Gruden Huddle Room was unveiled.

Gruden lends family name to fight cancer
Fox 13 – Dec. 17
Jon Gruden spoke at a news conference and dedication of the new room at Moffitt's McKinley Outpatient Center Thursday.

Holiday Hopes: Migrant mother hopes for Disney respite after cancer battle
Tampa Bay  Times – Dec. 17
When Venessa Rivera heard Rosalba's story, she wanted to do something special for the family.
"She's a warrior," said Rivera, who is a program manager for outreach wellness at Moffitt Cancer Center. "They need a respite and a chance for the children to celebrate their mother." 

Una nueva terapia bloquea el crecimiento del cáncer de pecho más maligno
Jornadanet.com – Dec. 17           
En el estudio, además de dos laboratorios del TSRI, una de las de las mayores organizaciones centrada en la investigación biomédica, también han participado científicos del Moffitt Cancer Center, también de Florida.

Girl Scouts of West Central Florida announce 2016 Women of Distinction
Tampa Bay Times – Dec. 17
Pam Muma, a philanthropist who has served as Florida State Chairwoman of Junior Achievement, past chairwoman of Tampa General Hospital Foundation and a member of Moffitt Cancer Center Board of Trustees. Last year, the University of South Florida's Muma College of Business was renamed for donors Pam Muma and her husband, Les.

Trigaux: At 130, Tampa chamber opts to be cool over all the heat on mass transit plan
Tampa Bay Times – Dec. 17
They praised the chamber's three trips to Cuba to push for a U.S. consulate in Tampa, or to partner the expertise of Tampa's Lions Eye Institute, a corneal tissue bank, or Tampa's Moffitt Cancer Center with Cuban doctors.

Terapia bloquea crecimiento de cáncer de pecho
Elsalvador.com – Dec. 17
En el estudio, además de dos laboratorios del TSRI, una de las de las mayores organizaciones centrada en la investigación biomédica, también han participado científicos del Moffitt Cancer Center, también de Florida. 

Slowly winning the war on cancer
Star2.com – Dec. 17
One of the ways cancer fights back is by mutating, said Dr Amod Sarnaik, an associate professor at Moffitt Cancer Center in Tampa, Florida, who specialises in melanoma.
“Melanoma is one of the most heavily mutated cancers there is,” he said.

New compound successfully targets hard-to-treat breast cancer
Medical Xpress – Dec. 16
The study, which was published today in the journal Science Translational Medicine, was a collaboration among the Florida labs of Derek Duckett and William R. Roush, both of TSRI, and John Cleveland, formerly of TSRI and currently at the Moffitt Cancer Center.

FDA expands Gardasil 9 HPV vaccine approval to boys, young men
Helio.com – Dec. 16
“While it is important to remember that the CDC’s ACIP recommends routine HPV vaccination at age 11 or 12, before exposure to the HPV virus, this expanded indication for GARDASIL 9 is exciting because now 16- through 26-year-old young men can get this HPV vaccine,” Anna Giuliano, PhD, clinical investigator for Gardasil 9 and director of the Center for Infection Research in Cancer at H. Lee Moffitt Cancer Center and Research Institute, said in the release. “It’s important that we collectively work to increase HPV vaccination rates to help prevent HPV-related cancers and diseases.”

Keylla Hernández envía emotivo mensaje
WAPA TV – Dec. 16
La reportera reveló el 9 de septiembre que padece de cáncer del pulmón. Desde entonces se mantiene viajando a Moffitt Cancer Center en Tampa, Florida para recibir tratamiento contra el cáncer.

Fast, fluid cells spread cancer
Inside Science – Dec. 16
Since most cancer-related deaths are the result of tumor metastatic spread, not the growth of the primary tumor, it is extremely important to investigate how the tumor cells reach the distant sites, said Katarzyna Rejniak, a mathematical oncologist at the Moffitt Cancer Center in Tampa, Florida.

Mantle Cell Lymphoma: New option for first-line Rituximab Plus Lelalidomide
Oncology Times – Dec. 16
For the Phase II study of 38 patients, researchers at four medical centers—Weill Cornell Medicine/NewYork Presbyterian, Moffitt Cancer Center, the University of Pennsylvania Abramson Cancer Center, and the University of Chicago Medical Center—conducted the study between July 2011 and April 2014. Patients had a median age of 65, and at baseline, 34 percent had low-risk disease, 34 percent had intermediate-risk, and 32 percent had high-risk disease. 

The Vulnerable Zone: Adjusting Care for Older Patients With Cancer
Cure Today – Dec. 15
“When you get into the late 70s and 80s, it’s rare to find somebody who has cancer and nothing else,” says Martine Extermann, a specialist in geriatric oncology at the H. Lee Moffitt Cancer Center at the University of South Florida. On average, she says, a patient in his or her 70s has three diseases, not including cancer.

Top research taking place in Tampa leads to national recognition for innovation, patents
83 Degrees – Dec. 15     
Besides USF, the inventions are coming from places like the H.L. Moffitt Cancer Center & Research Institute in Tampa and even the Lions Eye Institute in Ybor City. 

UCLA joins BMS’ Immuno-Oncology Research Program
GenEngNews - Dec. 14
The I-O RPM research program is a multi-institutional initiative with academic-based cancer centers focused on the clinical investigation of immuno-oncology therapeutics as potential treatment options for patients with high-risk, poor prognostic cancers, defined as a rare population malignancy. In September, Moffitt Cancer Center joined the program. 

Amid cancer breakthroughs, hospitals aim for top talent, clinical trials
Capital New York – Dec. 14
In September, Langone announced it had recruited immunotherapy expert Jeff Weber from the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida, to serve as co-director of Langone’s melanoma program.

Advances in cancer treatment aid former president Jimmy Carter — and others
HeraldNet – Dec. 14
One of the ways cancer fights back is by mutating, said Dr. Amod Sarnaik, an associate professor at Moffitt Cancer Center in Tampa, who specializes in melanoma.

Hospital staff sports blue mustaches to support Seffner cancer victim
WFLA – Dec. 13
Their little 11-year-old boy, Corbin, had metastic melanoma, an aggressive form of skin cancer. Before Corbin’s first surgery, Moffitt Cancer Center’s Dr. Wayne Cruz decided to draw something silly across Corbin’s face with that blue marker that is typically used to mark surgical incisions.

Pomalidomide and Ixazomib Pair Up in Refractory Myeloma
MedPage Today – Dec. 13
Ken Shain, MD, PhD, assistant member at the Moffitt Cancer Center and professor of oncologic sciences at the University of South Florida, Tampa, told MedPage Today, "Ixazomib has been approved about a week and it is already being combined with other drugs, as always happens, in treating relapsed or refractory multiple myeloma.

Advances in cancer treatment aid Jimmy Carter
Atlanta Journal-Constitution – Dec. 12
One of the ways cancer fights back is by mutating, said Dr. Amod Sarnaik, an associate professor at Moffitt Cancer Center in Tampa, who specializes in melanoma.

Filanesib Plus Carfilzomib Active in Myeloma
MedPage Today – Dec. 12
In commenting on the study, Ken Shain, MD, PhD, assistant member at Moffitt Cancer Center and professor of oncologic sciences at the University of South Florida, Tampa, told MedPage Today, "I am really intrigued by filanesib because it has excellent activity in a highly refractive patient populations.

Pomalidomide Safe in Renally-Impaired Myeloma Patients
MedPage Today – Dec. 12
Ken Shain, MD, PhD, assistant member at the Moffitt Cancer Center and professor of oncologic sciences at the University of South Florida, Tampa, told MedPage Today, "I think this is a confirmation of what we always understood about the metabolism and clearance of pomalidomide.

Rita Wilson is officially cancer-free
Inquisitr – Dec. 11
Rita Wilson’s brush with breast cancer has helped her become an advocate for breast cancer research. She is donating her time and money to the Moffitt Cancer Center and encouraging women to undergo routine breast cancer screenings.

Moddy’s affirms H. Lee Moffitt Cancer Center’s A3; Outlook stable
Moody’s Investors Service – Dec. 11
Moody's Investors Service affirms the A3 rating assigned to H. Lee Moffitt Cancer Center's (Moffitt) bonds issued through the City of Tampa and the Hillsborough County Industrial Development Authority. The rating outlook is stable. Approximately $143 million of debt is affected.

###

Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.